Further to DrugAlert volume 847, HPS Pharmacies advise that Organon Pharma is experiencing a supply interruption of Celestone® Chronodose® Injection Ampoule, as follows:
Celestone® Chronodose® Injection Ampoule
Betamethasone (as acetate and sodium phosphate) 5.7 mg/mL
Normal supplies are expected to return in the second half of 2023. During this period, supplies will be available on a restricted basis to critically ill patients. Specifically, Organon is prioritising supply for antepartum use in the prevention of respiratory distress syndrome in premature infants prior to 32 weeks of gestation.
This supply interruption is due to a recent drug recall. Batches affected by the recall are:
For further information on the drug recall, please see DrugAlert volume 847.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Organon Pharma on 1800 024 874 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates